ClinicalTrials.Veeva

Menu

CIFASD 5 tDCS and Cognitive Training

University of Minnesota (UMN) logo

University of Minnesota (UMN)

Status

Enrolling

Conditions

Fetal Alcohol Spectrum Disorders

Treatments

Device: Sham tDCS
Device: Active tDCS
Behavioral: Cognitive Training

Study type

Interventional

Funder types

Other

Identifiers

NCT05456321
PSYCH-2022-30910

Details and patient eligibility

About

This is a randomized placebo-controlled trial of cognitive training with transcranial direct current stimulation (tDCS) for children and adolescents (ages 8 - 17 years) with prenatal alcohol exposure (PAE).

Full description

Prenatal alcohol exposure (PAE) has profound detrimental effects on brain development and, as a result, has permanent consequences for cognition, learning, and behavior. Individuals with Fetal Alcohol Spectrum Disorders (FASD) commonly have a range of neurocognitive impairments that directly lead to practical problems with learning, attention, working memory, task planning/execution, and decision making, among other areas of functioning. Despite the profound public health burden posed by FASD, there have been very few treatment studies in this population. This study will examine the effects of a cognitive remediation training augmented with transcranial direct current stimulation (tDCS) in children and adolescents with PAE. The study involves a baseline visit with cognitive testing, 5 sessions of tDCS (including the baseline visit) with active and sham arms, a 6th visit for cognitive testing.

Enrollment

70 estimated patients

Sex

All

Ages

8 to 17 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Documented heavy prenatal alcohol exposure (self-report, social service records, or adoption records) and meeting criteria for an associated FASD diagnosis (FAS, partial FAS, or ARND).
  • An available parent or legal guardian capable of giving informed consent

Exclusion criteria

  • Substance abuse in the participant
  • Neurological condition or other developmental disorder
  • Serious psychiatric disorder known to affect brain functioning and cognitive performance Birthweight < 1500 grams
  • MRI contraindication
  • tDCS contraindication

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

70 participants in 2 patient groups

Cognitive Training and Active tDCS
Active Comparator group
Description:
5 sessions of computerized executive functioning training - plus active tDCS (also 5 sessions).
Treatment:
Behavioral: Cognitive Training
Device: Active tDCS
Cognitive Training and Sham tDCS
Sham Comparator group
Description:
5 sessions of computerized executive functioning training - plus sham tDCS (also 5 sessions).
Treatment:
Behavioral: Cognitive Training
Device: Sham tDCS

Trial documents
1

Trial contacts and locations

1

Loading...

Central trial contact

Jeffrey Wozniak, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems